US2024024404A1PendingUtilityA1

Therapeutic use of chardonnay seed products

78
Assignee: SONOMACEUTICALS LLCPriority: Apr 30, 2012Filed: Jun 22, 2023Published: Jan 25, 2024
Est. expiryApr 30, 2032(~5.8 yrs left)· nominal 20-yr term from priority
A61K 36/87A61P 3/04A61P 3/10
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure relates to health benefits of Chardonnay seed products.

Claims

exact text as granted — not AI-modified
1 - 57 . (canceled) 
     
     
         58 . A method of treating metabolic syndrome in a mammal in need thereof comprising administering to the mammal in need thereof an effective amount of Chardonnay pomace. 
     
     
         59 . The method of  claim 58 , wherein the treating metabolic syndrome reduces cholesterol of the mammal. 
     
     
         60 . The method of  claim 58 , wherein the treating metabolic syndrome reduces the weight of the mammal. 
     
     
         61 . The method of  claim 58 , wherein the treating metabolic syndrome reduces the weight of the liver of the mammal. 
     
     
         62 . The method of  claim 58 , wherein the treating metabolic syndrome restores blood glucose levels to normal in the mammal. 
     
     
         63 . The method of  claim 58 , wherein the mammal is a human. 
     
     
         64 . A method of reducing the weight of a liver or reducing cholesterol in a mammal in need thereof comprising administering to the mammal in need thereof an effective amount of Chardonnay pomace. 
     
     
         65 . The method of  claim 64 , wherein the method comprises reducing the weight of the liver in the mammal. 
     
     
         66 . The method of  claim 64 , wherein the method comprises reducing cholesterol in the mammal. 
     
     
         67 . The method of  claim 64 , wherein the mammal is a human. 
     
     
         68 . The method of  claim 64 , wherein the Chardonnay pomace is cold pressed dried or hot pressed dried. 
     
     
         69 . A method of treating diabetes, increasing lipid metabolism, reducing weight, treating dyslipoproteinemia, increasing the amount of  Bacteroides fragilis  in the gut, decreasing the amount of Enterobacteriaceae bacteria in the gut, increasing the amount of  Clostridium  bacteria in the gut, or treating lactic acidosis in a mammal in need thereof, the method comprising administering to the mammal in need thereof an effective amount of Chardonnay pomace. 
     
     
         70 . The method of  claim 69 , wherein the mammal is a human. 
     
     
         71 . The method of  claim 69 , wherein the effective amount is at least 0.2 g/kg of body weight is administered to the mammal. 
     
     
         72 . The method of  claim 69 , wherein the effective amount is at least 1.0 g per day is administered to the mammal.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.